# Dilek Dogan Gurluk chosen as The Irish Times Business Person of the Month.

*biotech · news · 2026-04-17 · The Irish Times*

## Key points

- Novo Nordisk will invest €432 million to upgrade its Athlone plant for Wegovy tablet production.
- The Athlone plant, acquired for €85 million in 2024, will serve markets outside the United States.
- Construction on the Athlone upgrade has already begun, with completion expected in 2028.
- Novo Nordisk produces the Wegovy obesity pill for the U.S. market exclusively within the United States.

**Companies:** Novo Nordisk
**Countries:** Ireland, Denmark

[Read the full story on The Irish Times](https://www.irishtimes.com/business/2026/04/17/the-irish-times-business-person-of-the-month-dilek-dogan-gurluk-country-head-novo-nordisk/)

---

Canonical: https://newsio.io/n/9101cfef-9242-4f9f-b9f0-92b28ec26e3c/dilek-dogan-gurluk-chosen-as-the-irish-times-business-person-of-the-month-novo-n
Summarized by Newsio from The Irish Times. https://newsio.io/how-it-works